E&C DEMOCRATS INTRODUCE PAHPA REAUTHORIZATION ALTERNATIVE THAT APPLIES THE LESSONS LEARNED FROM COVID-19 PANDEMIC

Press Release

"Republican leadership is willing to put American lives at risk with their refusal to address the nation's drug shortage crisis in their PAHPA bill. Drug shortages are at a five-year high, we are currently in the throes of the worst chemotherapy shortage in decades, and doctors are being forced to ration treatment. Our bill includes many bipartisan priorities, including my bills the Doctors at the Ready Act, which will streamline hiring for the National Disaster Medical System and the Diagnostic Testing Preparedness Plan Act which will facilitate the innovation and development of diagnostics between the private and public sectors during Public Health Emergencies. The bill also includes the Drug Shortage Prevention Act which would require manufacturers to notify the FDA if they experience six consecutive weeks of an increase in product demand to minimize drug shortages and improve the FDA's predictive ability and responsiveness. We can't afford to let partisanship hinder our pandemic response, and I am hopeful that we can work together to apply what we have learned from the COVID pandemic to prepare for our future emergencies, not refuse policies that would provide relief."

Source